Acute coronary syndrome (ACS) leads to millions of hospital admissions worldwide each year and is a leading cause of death. Antithrombotic therapies are a cornerstone in the immediate and long-term management of ACS, reducing the risk of myocardial infarction (MI) and death in both medically and invasively managed patients. This chapter reviews fibrinolytic, antiplatelet, and anticoagulant therapies in the treatment of patients with ACS and provides a practical guide to several common hemostatic and thrombotic problems encountered in this patient population.
Authors
Eikelboom JW; Weitz JI
Book title
Hematology Basic Principles and Practice Eighth Edition